Comparing arm function in children with and without hemophilia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study compares how well children with hemophilia use their arms and hands compared to healthy children. If your child has hemophilia A or B, is on regular treatment, and has no inhibitors or recent bleeds in the arm, they may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a child age 5–18 diagnosed with hemophilia A or B
- They must be on regular preventive treatment (prophylaxis)
- They must not have inhibitors (antibodies that block factor) at enrollment
- No active elbow bleeding or history of muscle bleeds in the upper arm
- No past surgery on any upper limb joint
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise program helps children with hemophilia A or B safely. It looks at children’s ability to exercise and function, while aiming to avoid complications like leg bleeds or injuries.
This study tests whether a special type of strength training can improve knee function in boys with hemophilia who have had bleeding in one knee. It may help them walk and move better.
This study looks at the oral health and quality of life related to oral health in children with hemophilia. It aims to understand how hemophilia affects dental health and daily life.
This study tests a simple 2-minute step test to see if it's a good way to measure fitness in children and teens with hemophilia. You'll be asked to step in place for two minutes while researchers watch your heart rate and how you feel.
This trial uses ultrasound to check if healthy joints in people with hemophilia A develop damage while being treated with emicizumab (Hemlibra). It looks at elbows, knees, and ankles over time to see if the medicine prevents joint problems.
This study compares how well people with hemophilia (ages 18–35) can do a 30-second sit-to-stand test compared to healthy people of the same age. It helps understand if hemophilia affects leg strength and endurance.
Hear when a new Upper Extremity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.